Skip to main content

Penumbra Consumption Rates Based on Time-to-Maximum Delay and Reperfusion Status: A Post Hoc Analysis of the DEFUSE 3 Trial.

Publication ,  Journal Article
Yaghi, S; Raz, E; Dehkharghani, S; Riina, H; McTaggart, R; Jayaraman, M; Prabhakaran, S; Liebeskind, DS; Khatri, P; Mac Grory, B; Al-Mufti, F ...
Published in: Stroke
August 2021

BACKGROUND AND PURPOSE: In patients with acute large vessel occlusion, the natural history of penumbral tissue based on perfusion time-to-maximum (Tmax) delay is not well established in relation to late-window endovascular thrombectomy. In this study, we sought to evaluate penumbra consumption rates for Tmax delays in patients with large vessel occlusion evaluated between 6 and 16 hours from last known normal. METHODS: This is a post hoc analysis of the DEFUSE 3 trial (The Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke), which included patients with an acute ischemic stroke due to anterior circulation occlusion within 6 to 16 hours of last known normal. The primary outcome is percentage penumbra consumption, defined as (24-hour magnetic resonance imaging infarct volume-baseline core infarct volume)/(Tmax 6 or 10 s volume-baseline core volume). We stratified the cohort into 4 categories based on treatment modality and Thrombolysis in Cerebral Infarction (TICI score; untreated, TICI 0-2a, TICI 2b, and TICI3) and calculated penumbral consumption rates in each category. RESULTS: We included 141 patients, among whom 68 were untreated. In the untreated versus TICI 3 patients, a median (interquartile range) of 53.7% (21.2%-87.7%) versus 5.3% (1.1%-14.6%) of penumbral tissue was consumed based on Tmax >6 s (P<0.001). In the same comparison for Tmax>10 s, we saw a difference of 165.4% (interquartile range, 56.1%-479.8%) versus 25.7% (interquartile range, 3.2%-72.1%; P<0.001). Significant differences were not demonstrated between untreated and TICI 0-2a patients for penumbral consumption based on Tmax >6 s (P=0.52) or Tmax >10 s (P=0.92). CONCLUSIONS: Among extended window endovascular thrombectomy patients, Tmax >10-s mismatch volume may comprise large volumes of salvageable tissue, whereas nearly half the Tmax >6-s mismatch volume may remain viable in untreated patients at 24 hours.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Stroke

DOI

EISSN

1524-4628

Publication Date

August 2021

Volume

52

Issue

8

Start / End Page

2690 / 2693

Location

United States

Related Subject Headings

  • Time-to-Treatment
  • Thrombectomy
  • Stroke
  • Neurology & Neurosurgery
  • Middle Aged
  • Male
  • Humans
  • Female
  • Endovascular Procedures
  • Cerebrovascular Circulation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yaghi, S., Raz, E., Dehkharghani, S., Riina, H., McTaggart, R., Jayaraman, M., … de Havenon, A. (2021). Penumbra Consumption Rates Based on Time-to-Maximum Delay and Reperfusion Status: A Post Hoc Analysis of the DEFUSE 3 Trial. Stroke, 52(8), 2690–2693. https://doi.org/10.1161/STROKEAHA.120.033806
Yaghi, Shadi, Eytan Raz, Seena Dehkharghani, Howard Riina, Ryan McTaggart, Mahesh Jayaraman, Shyam Prabhakaran, et al. “Penumbra Consumption Rates Based on Time-to-Maximum Delay and Reperfusion Status: A Post Hoc Analysis of the DEFUSE 3 Trial.Stroke 52, no. 8 (August 2021): 2690–93. https://doi.org/10.1161/STROKEAHA.120.033806.
Yaghi S, Raz E, Dehkharghani S, Riina H, McTaggart R, Jayaraman M, et al. Penumbra Consumption Rates Based on Time-to-Maximum Delay and Reperfusion Status: A Post Hoc Analysis of the DEFUSE 3 Trial. Stroke. 2021 Aug;52(8):2690–3.
Yaghi, Shadi, et al. “Penumbra Consumption Rates Based on Time-to-Maximum Delay and Reperfusion Status: A Post Hoc Analysis of the DEFUSE 3 Trial.Stroke, vol. 52, no. 8, Aug. 2021, pp. 2690–93. Pubmed, doi:10.1161/STROKEAHA.120.033806.
Yaghi S, Raz E, Dehkharghani S, Riina H, McTaggart R, Jayaraman M, Prabhakaran S, Liebeskind DS, Khatri P, Mac Grory B, Al-Mufti F, Lansberg M, Albers G, de Havenon A. Penumbra Consumption Rates Based on Time-to-Maximum Delay and Reperfusion Status: A Post Hoc Analysis of the DEFUSE 3 Trial. Stroke. 2021 Aug;52(8):2690–2693.

Published In

Stroke

DOI

EISSN

1524-4628

Publication Date

August 2021

Volume

52

Issue

8

Start / End Page

2690 / 2693

Location

United States

Related Subject Headings

  • Time-to-Treatment
  • Thrombectomy
  • Stroke
  • Neurology & Neurosurgery
  • Middle Aged
  • Male
  • Humans
  • Female
  • Endovascular Procedures
  • Cerebrovascular Circulation